✦ For everyone, free.

Practical knowledge for real and everyday life

Home

Myocardial Relaxation Physiology

Myocardial relaxation physiology explains how the heart muscle relaxes after contraction, essential for efficient cardiac function and blood flow regulation.

Myocardial Relaxation Physiology is the study of the active and passive processes by which cardiac muscle returns from the contracted, systolic state to the relaxed, diastolic state, encompassing the biochemical reversal of the calcium and cross-bridge cycling events that produced contraction as well as the passive elastic recoil of the ventricular wall, and providing the mechanistic basis for adequate ventricular filling and, ultimately, effective stroke volume on the subsequent beat.


Active Relaxation Mechanisms

Reversal of the Calcium Transient

Relaxation begins with the decline of cytoplasmic calcium concentration following the peak of the systolic transient, driven predominantly by active reuptake into the sarcoplasmic reticulum via the SERCA2a calcium pump and, to a lesser degree, extrusion across the sarcolemma via the sodium-calcium exchanger, progressively reducing calcium available to bind troponin C.

Cross-Bridge Detachment

As cytoplasmic calcium falls, calcium dissociates from troponin C, permitting tropomyosin to return toward its blocking position on the thin filament, progressively reducing the number of new cross-bridges able to form and allowing existing cross-bridges to complete their cycle and detach without re-engaging, the direct mechanical basis of declining force during relaxation.

Ca2+ troponin C binding cross-bridge cycling

Energy Dependence of Relaxation

Because SERCA-mediated calcium reuptake is an active, ATP-dependent process, myocardial relaxation is itself energy-consuming rather than a purely passive process, meaning conditions that impair myocardial energy supply can impair relaxation even before they measurably impair systolic contractile force.


Phases of Diastolic Filling

Isovolumic Relaxation

Following aortic valve closure, the ventricle relaxes at constant volume (isovolumic relaxation) while intraventricular pressure falls rapidly, a phase whose rate is characterized by the time constant of pressure decay and reflects the speed of the underlying active relaxation processes described above.

Rapid Filling Phase

Once ventricular pressure falls below atrial pressure, the atrioventricular valves open and blood flows rapidly into the ventricle, a phase driven substantially by elastic recoil of the ventricular wall (restoring energy stored during systolic compression, partly attributable to titin and other cytoskeletal elements) in addition to the pressure gradient from the atrium.

Diastasis and Atrial Contraction

Following rapid filling, a period of slow, near-equilibrium filling (diastasis) occurs before atrial contraction contributes a final increment of ventricular filling, together completing the diastolic filling process in preparation for the next systolic contraction.


Determinants of Relaxation Rate

Rate of Calcium Reuptake

The rate of SERCA2a-mediated calcium reuptake, itself governed by SERCA2a expression level and the phosphorylation state of its regulatory partner phospholamban, is a principal determinant of how rapidly the cytoplasmic calcium transient declines and therefore how rapidly active relaxation proceeds.

Myofilament Calcium Dissociation Kinetics

The rate at which calcium dissociates from troponin C, modulated by troponin I phosphorylation state, independently influences relaxation rate; faster calcium dissociation from the myofilaments permits more rapid cross-bridge detachment even at a given rate of bulk cytoplasmic calcium decline.

Passive Ventricular Stiffness

Beyond active relaxation, the passive mechanical properties of the ventricular wall—determined by titin isoform composition, myocardial fibrosis, and chamber geometry—govern the pressure-volume relationship during diastolic filling independent of any active biochemical process, and abnormal passive stiffness can impair filling even when active relaxation itself is normal.


Beta-Adrenergic Modulation of Relaxation (Lusitropy)

The Lusitropic Effect

Sympathetic stimulation produces a positive lusitropic effect—accelerated relaxation—through the same protein kinase A-mediated phosphorylation cascade responsible for its positive inotropic effect: phospholamban phosphorylation accelerates SERCA-mediated reuptake, while troponin I phosphorylation accelerates calcium dissociation from the myofilaments, together shortening the time course of relaxation.

Physiological Necessity of Coupled Inotropy and Lusitropy

Because increased heart rate shortens the total duration of the cardiac cycle, and diastole shortens disproportionately relative to systole as heart rate rises, the lusitropic acceleration of relaxation accompanying sympathetic stimulation is physiologically necessary to preserve adequate diastolic filling time despite the faster heart rate that increased sympathetic drive typically also produces.


Diastolic Dysfunction

Impaired Active Relaxation

Conditions that impair calcium handling—reduced SERCA2a expression or activity, altered phospholamban regulation, myocardial ischemia limiting ATP availability—slow the rate of isovolumic pressure decline and early diastolic filling, producing impaired relaxation, one principal category of diastolic dysfunction.

Increased Passive Stiffness

Independent of active relaxation abnormalities, myocardial hypertrophy, fibrosis, or infiltrative disease increases passive ventricular stiffness, requiring higher filling pressures to achieve a given diastolic volume and producing the second principal category of diastolic dysfunction, often coexisting with impaired active relaxation in clinical heart failure with preserved ejection fraction.

Clinical Consequences

Because adequate diastolic filling is a prerequisite for effective Frank-Starling-mediated stroke volume on the subsequent beat, impaired relaxation physiology—whether from active or passive mechanisms—can produce clinically significant heart failure symptoms even when systolic ejection fraction remains within a normal range, underscoring relaxation physiology as functionally distinct from, though intimately connected to, systolic contractile performance.